Unicycive Therapeutics Incの株価・株式情報
企業概要
Unicycive Therapeutics is a biotechnology company dedicated to developing treatments for certain medical conditions. Co.'s development programs are focused on the development of two novel therapies: Renazorb, for treatment of hyperphosphatemia in patients with chronic kidney disease, and UNI 494, for treatment of acute kidney injury (AKI).
